Skip to main content
. Author manuscript; available in PMC: 2010 Oct 28.
Published in final edited form as: J Med Chem. 2008 Jul 8;51(15):4708–4714. doi: 10.1021/jm800422v

Figure 3.

Figure 3

Control compounds designed by removing the functionality from the 4-postion (14b) or by methylating the oxalamide (15a–c). Control compounds are >30-fold less potent than their parent compound (listed below the compound in parenthesis) when tested against hGX (14b and 15a), human and mouse GIIA, GV, and GX (15b), or human GIIA (15c).